Subsequently, our understanding and characterisation of these host-pathogen binding patterns could represent a critical point at which the adherence of ETEC expressing CFA/I and related CF family members, can be prevented with vaccines and/or anti-infection therapeutics that block this interaction (Fig. 6). This evidence concerns the gene CFTR and infection.